Search Results

There are 117161 results for: content related to: Data sources on drug safety evaluation: a review of recent published meta-analyses

  1. Safety aspects of antiepileptic drugs—focus on pharmacovigilance

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 11–20, Cecilie Johannessen Landmark and Svein I. Johannessen

    Version of Record online : 8 NOV 2011, DOI: 10.1002/pds.2269

  2. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 442–449, Tim A. Bruckner, Ashley Hodgson, Chris Brown Mahoney, Brent D. Fulton, Peter Levine and Richard M. Scheffler

    Version of Record online : 24 OCT 2011, DOI: 10.1002/pds.2264

  3. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1168–1176, Susan E. Andrade, Tiffany A. Moore Simas, Denise Boudreau, Marsha A. Raebel, Sengwee Toh, Beth Syat, Inna Dashevsky and Richard Platt

    Version of Record online : 22 AUG 2011, DOI: 10.1002/pds.2217

  4. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1064–1072, Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg and Anke-Hilse Maitland-van der Zee

    Version of Record online : 24 AUG 2011, DOI: 10.1002/pds.2228

  5. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 254–260, Christiane Eickhoff, Andrea Hämmerlein, Nina Griese and Martin Schulz

    Version of Record online : 27 SEP 2011, DOI: 10.1002/pds.2241

  6. Record linkage for pharmacoepidemiological studies in cancer patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 94–103, Myrthe P. P. van Herk-Sukel, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse, Ron M. C. Herings and Jan Willem W. Coebergh

    Version of Record online : 2 AUG 2011, DOI: 10.1002/pds.2205

  7. Stroke risk and NSAIDs: a systematic review of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1225–1236, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom and Susana Perez-Gutthann

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pds.2227

  8. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1130–1137, Rolf H. H. Groenwold, Frank de Vries, Anthonius de Boer, Wiebe R. Pestman, Frans H. Rutten, Arno W. Hoes and Olaf H. Klungel

    Version of Record online : 23 SEP 2011, DOI: 10.1002/pds.2251

  9. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 920–928, Emily S. Brouwer, Suzanne L. West, Marianne Kluckman, Dennis Wallace, Andrew L. Masica, Edward Ewen, Rustam Kudyakov, Dunlei Cheng, James Bowen and Neil S. Fleming

    Version of Record online : 16 JAN 2012, DOI: 10.1002/pds.2262

  10. Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1045–1052, Øystein Karlstad, Per Nafstad, Aage Tverdal, Svetlana Skurtveit and Kari Furu

    Version of Record online : 23 SEP 2011, DOI: 10.1002/pds.2233

  11. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 214–225, Michael C. Irizarry, David J. Webb, Nada Boudiaf, John Logie, Laurel A. Habel, Natalia Udaltsova and Gary D. Friedman

    Version of Record online : 6 DEC 2011, DOI: 10.1002/pds.2266

  12. Major bleeding risk associated with warfarin and co-medications in the elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1057–1063, Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Adrian K. Preiss, Philip Ryan, Andrew L. Gilbert, Gillian E. Caughey, Sepehr Shakib, Adrian Esterman, Ying Zhang and Robyn A McDermott

    Version of Record online : 17 AUG 2011, DOI: 10.1002/pds.2219

  13. The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 177–183, Judith E. Fisher, Ying Zhang, Ingrid Sketris, Grace Johnston and Fred Burge

    Version of Record online : 14 NOV 2011, DOI: 10.1002/pds.2259

  14. Antipsychotic drugs and risk of pulmonary embolism

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 42–48, Benoit Allenet, Sophie Schmidlin, Céline Genty and Jean-Luc Bosson

    Version of Record online : 4 NOV 2011, DOI: 10.1002/pds.2210

  15. Use and costs of oral anticancer agents in the Netherlands in the period 2000–2008

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1036–1044, Lonneke Timmers, Jan Jacob Beckeringh, Myrthe P. P. van Herk-Sukel, Epie Boven and Jacqueline G. Hugtenburg

    Version of Record online : 29 SEP 2011, DOI: 10.1002/pds.2225

  16. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 79–86, Maria Bygdell, Gertrud Brunlöf, Susanna M. Wallerstedt and Jenny M. Kindblom

    Version of Record online : 10 NOV 2011, DOI: 10.1002/pds.2265

  17. You have free access to this content
    A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 100–128, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg and Jerry H. Gurwitz

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2312

  18. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1043–1049, Fei-Yuan Hsiao, C. Daniel Mullins, Yu-Wen Wen, Weng-Foung Huang, Pei-Fen Chen and Yi-Wen Tsai

    Version of Record online : 8 AUG 2011, DOI: 10.1002/pds.2202

  19. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 161–169, Philip Prah, Irene Petersen, Irwin Nazareth, Kate Walters and David Osborn

    Version of Record online : 19 AUG 2011, DOI: 10.1002/pds.2213

  20. Exposure to inhibitors of the renin–angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case–control study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 314–319, Guillaume Moulis, Laurent Sailler, Agnès Sommet, Maryse Lapeyre-Mestre, Jean-Louis Montastruc and the French Association of Regional Pharmacovigilance Centers

    Version of Record online : 27 SEP 2011, DOI: 10.1002/pds.2253